CEMEX SAB DE CV current report, Q1 FY2025 (NYSE:CX)

Business Context and Reporting Period

Company: CEMEX SAB DE CV (Cemex)

Filing Type: Form 6-K (Report of Foreign Private Issuer)

Reporting Date: March 26, 2025

Event: Notification of resolutions adopted at the Extraordinary General Shareholders' Meeting held on March 25, 2025.

Attendance: 42,864,549,735 shares were represented, constituting 98.48% of the total voting capital stock.

This filing is a corporate governance report regarding Bylaw amendments and does not contain financial performance data.

Revenue, Profit, Cash Flow, Margins: Not provided in this filing.
Debt and Liquidity: Not provided in this filing.
Capital Stock: The restated Bylaws confirm a Minimum Fixed Capital of $36,300,000.00 MXN represented by 13,068,000,000 ordinary shares (Series A and Series B). Variable Capital is unlimited.

The filing details significant amendments to the Company's Bylaws approved by shareholders. There are no financial material changes reported.

Board Meetings (Article 23): Amended to explicitly allow meetings via electronic, optical, or technological means with the same validity as in-person meetings. Resolutions adopted remotely must be confirmed in writing and signed by all attendees.
Board Responsibilities (Article 27): Expanded to include specific duties regarding related party transactions, risk management, and the appointment/removal of the CEO. The Board must approve transactions involving assets or liabilities equal to or greater than 5% of consolidated assets.
CEO Faculties (Article 28): Clarified the CEO's authority to represent the Company in legal and labor proceedings and manage assets, subject to Board strategies.
Committees (Article 31): Formalized the structure of the Audit and Corporate Practices Committees, requiring them to be comprised solely of independent directors. Meetings may also be held electronically.
Signatures (Transitory Article 3): Defined "signature" to include methods established by Mexican law, accommodating digital signatures.

Management Commentary: The filing contains no management commentary on business outlook, guidance, or market conditions.

Risks and Contingencies:

Shareholding Restrictions: The restated Bylaws maintain strict restrictions on Series "A" shares, prohibiting acquisition by foreign individuals or entities without a foreign exclusion clause.
Forced Public Offer: Any transaction resulting in a participation of 30% or more of the Capital Stock triggers a mandatory forced public offer for the acquisition of all shares.
Related Party Transactions: Enhanced oversight is required for transactions with related parties, requiring Board approval for material transactions.

Bylaw Restatement: Verify the effective date of the restated Bylaws (March 25, 2025) and the specific thresholds for Board approval of asset sales (5% of consolidated assets).
Electronic Governance: Confirm the Company's internal protocols for validating electronic Board and Committee resolutions as per the new Bylaw language.
Shareholder Voting: Note the high attendance (98.48%) and the minimal opposition (0.25% on the first item) to the Bylaw amendments.
Foreign Ownership Limits: Review the continued restrictions on foreign ownership of Series "A" shares and the implications for potential acquirers.
Notarization: Four specific individuals were appointed to notarize the minutes and register the resolutions with the Public Registry of Commerce.